Glaucoma, Depression and Quality of Life: Multiple Comorbidities, Multiple Assessments and Multidisciplinary Plan Treatment

Pelčić, Goran; Ljubičić, Rudolf; Barać, Josip; Biuk, Dubravka; Rogoić, Veljko

doi:10.24869/psyd.2017.351

Cited by 9 publications

(4 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Помимо ухудшения качества жизни вследствие ухудшения зрения даже при сохранных зрительных функциях при начальной стадии глаукомы на качество жизни больных могут влиять побочные эффекты медикаментозной терапии [23]. Однако, несмотря на большое число тематических работ, ряд важных аспектов остается малоизученным: так, авторы обзорных статей, посвященных управлению автомобилем при глаукоме или ассоциации депрессии с глаукомой [24,25], приходят к выводу о необходимости дальнейшей разработки данных направлений.…”

Section: качество жизни пациентов при глаукомеunclassified

Impact of glaucoma and glaucoma surgery on quality of life

Erichev¹,

Volzhanin²

2022

Russian Journal of Clinical Ophthalmology

View full text Add to dashboard Cite

Glaucoma is a chronic, incurable disease managed by controlling intraocular pressure (IOP). Meanwhile, vision loss in glaucoma and treatments affect the quality of life (QoL). Many studies on QoL in patients with glaucoma are now available. Standardized questionnaires and established non-linear relationships between QoL in glaucoma and clinically assessed quantitative parameters (e.g., visual acuity, visual fields, etc.) are significant achievements. Although treatments (pharmacotherapy or surgical interventions) generally reduce IOP, their adverse reactions affect QoL and treatment adherence. Surgical interventions provide the most potent IOP-lowering effect. However, surgery most affects QoL due to local symptoms and psychological factors (particularly at the early stages of glaucoma). Given the emergence of minimally invasive procedures, the importance of studying de facto QoL after glaucoma surgery is resurrected. Keywords: quality of life, glaucoma, trabeculectomy, minimally invasive glaucoma surgery, neuroprotective therapy. For citation: Erichev V.P., Volzhanin A.V. Impact of glaucoma and glaucoma surgery on quality of life. Russian Journal of Clinical Ophthalmology. 2022;22(1):44–50 (in Russ.). DOI: 10.32364/2311-7729-2022-22-1-44-50.

show abstract

Section: качество жизни пациентов при глаукомеunclassified

Impact of glaucoma and glaucoma surgery on quality of life

Erichev¹,

Volzhanin²

2022

Russian Journal of Clinical Ophthalmology

View full text Add to dashboard Cite

show abstract

“…14,15 Logo, torna-se importante a identificação de seus fatores de risco, para que o diagnóstico e início do tratamento sejam feitos precocemente. 16,17 Tal processo possibilita o retardo da progressão da doença e a prevenção da cegueira. Para melhor controle no tratamento de glaucomas refratários mesmo após trabeculotomia são utilizados implantes de drenagem (TUBO) , que são dispositivos artificiais que criam uma comunicação entre câmara anterior e espaço subtenoniano, cujo objetivo é a criação de uma bolha filtrante na região orbitária, após a formação de uma cápsula ao redor do prato, sendo distendida pela pressão intraocular.…”

Section: Discussãounclassified

A Importância Do Glaucoma Sobre O Ponto De Vista Epidemiológico Do Tratamento Clínico E Cirúrgico Na Região Sudeste Do Brasil Nos Últimos 5 Anos / the Importance of Glaucoma on the Epidemiological Point of View of Clinical and Surgical Treatment in the Southeast Region of Brazil in the Last 5 Years

Castro

Pinto

Innocencio

et al. 2020

BJD

View full text Add to dashboard Cite

Glaucoma é uma neuropatia óptica crônica e progressiva, de origem multifatorial que acomete o disco óptico e/ou camada de fibras nervosas da retina. Essa patologia cursa com redução da acuidade visual e consequente declínio na qualidade de vida dos pacientes, sendo atualmente a principal causa de cegueira irreversível do mundo. Traçar o perfil epidemiológico de pacientes portadores de glaucoma nos últimos 5 anos na região Sudeste do Brasil. Foi realizada uma revisão sistemática da literatura, buscando artigos publicados a partir de 2009, em inglês e português, nas bases Scielo e Pubmed. Além disso, foi realizada uma coleta de dados no SIA/SUS buscando informações acerca do número total e custo dos tratamentos para glaucoma, da faixa etária, etnia e gênero, das terapias medicamentosas entre janeiro de 2015 e dezembro de 2019. Ainda no SIA/SUS foi realizada coleta de dados referentes ao número de procedimentos cirúrgicos realizados e seus respectivos custos para a região Sudeste entre janeiro de 2015 e dezembro de 2019. Houve crescimento progressivo no número de tratamentos oftalmológicos para glaucoma e no número de procedimentos cirúrgicos para tratamento do glaucoma. A faixa etária mais prevalente e que apresentou maior crescimento foi a de 60 a 79 anos, correspondendo a 57,1% dos tratamentos farmacológicos. Os resultados sugerem que o glaucoma possui uma prevalência crescente na região Sudeste. Dessa forma, faz-se necessário medidas que possibilitem um diagnóstico precoce visando reduzir gastos e o impacto na qualidade de vida dos pacientes portadores da doença.

show abstract

“…In case of patients with non-diagnosed OAG the raise in IOP can lead to severe aggravation of the disease, which can pass unnoticed until advanced stages [19]. On the other hand, glaucoma patients may exhibit a wide array of psychiatric symptoms, as a consequence of progression of vision loss, such as depression [20], anxiety [21] and insomnia [22].…”

Section: Introductionmentioning

confidence: 99%

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Ciobanu

Dionisie

Neagu

et al. 2021

JCM

View full text Add to dashboard Cite

Through the years, the available psychopharmacological treatments have expanded with numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like symptoms, ocular adverse effects of psychiatric drugs have been reported. These adverse effects are not common, but can be dangerous for the patient. This review summarises the current knowledge on the risk of raised intraocular pressure and glaucoma entailed by psychopharmacological treatment. Also, it provides updated data for clinicians involved in the treatment of patients with glaucoma or glaucoma risk factors. For this purpose, we performed an extensive literature search in the PubMed database using specific terms. Selective serotonin and noradrenaline reuptake inhibitors are the best evidenced as having no association with glaucoma. Antipsychotics, and especially first generation, seem to have no correlation with an increased intraocular pressure and therefore possibly with a risk of glaucoma, although a special attention should be paid when using ziprasidone. Tricyclic antidepressants, benzodiazepines and topiramate should be avoided in patients diagnosed with glaucoma or at risk. Clinicians should be aware of the possible psychotropic drug induced glaucoma and monitor at risk patients closely in order to prevent this condition. Irrespective of the psychopharmacological regimen taken into consideration, the glaucoma patient should be under the strict supervision of the ophthalmologist.

show abstract

Glaucoma, Depression and Quality of Life: Multiple Comorbidities, Multiple Assessments and Multidisciplinary Plan Treatment

Abstract: SUMMARY

Cited by 9 publications

References 48 publications

Impact of glaucoma and glaucoma surgery on quality of life

Impact of glaucoma and glaucoma surgery on quality of life

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Contact Info

Product

Resources

About